By Professor Ric Day

Journal articles

Ng DY; Stocker SL; Graham GG; Williams KM; Day RO, 2011, 'Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers', European Journal of Clinical Pharmacology, 67, pp. 709 - 713, http://dx.doi.org/10.1007/s00228-010-0963-6

Sklar P; Ripke S; Scott LJ; Andreassen OA; Cichon S; Craddock N; Edenberg HJ; Nurnberger JI; Rietschel M; Blackwood D; Corvin A; Flickinger M; Guan W; Mattingsdal M; McQuillan A; Kwan P; Wienker TF; Daly MJ; Dudbridge F; Holmans PA; Lin D; Burmeister M; Greenwood TA; Hamshere ML; Muglia P; Smith EN; Zandi PP; Nievergelt CM; McKinney R; Shilling PD; Schork NJ; Bloss CS; Foroud T; Koller DL; Gershon ES; Liu C; Badner JA; Scheftner WA; Lawson WB; Nwulia EA; Hipolito M; Coryell W; Rice J; Byerley W; McMahon FJ; Schulze TG; Berrettini W; Lohoff FW; Potash JB; Mahon AP; McInnis MG; Zollner S; Zhang P; Craig DW; Szelinger S; Barrett TB; Breuer R; Meier S; Strohmaier J; Witt SH; Tozzi F; Farmer A; McGuffin P; Strauss J; Xu W; Kennedy JL; Vincent JB; Matthews K; Day R; Ferreira MA; O'Dushlaine C; Perlis R; Raychaudhuri S; Ruderfer D; Hyoun PL; Smoller JW; Li J; Absher D; Thompson RC; Meng FG; Schatzberg A; Bunney WE; Barchas JD; Jones EG; Watson SJ; Myers RM; Akil H; Boehnke M; Chambert K; Moran J; Scolnick EM; Djurovic S; Melle I; Morken G; Gill M; Morris D; Quinn E; Muhleisen TW; Degenhardt FA; Mattheisen M; Schumacher J; Maier W; Steffens M; Propping P; Nothen MM; Anjorin A; Bass N; Gurling H; Kandaswamy R; Lawrence J; McGhee K; McIntosh A; McLean AW; Muir WJ; Pickard BS; Breen G; St Clair D; Caesar S; Gordon-Smith K; Jones L; Fraser C; Green EK; Grozeva D; Jones IR; Kirov G; Moskvina V; Nikolov I; O'Donovan MC; Owens MJ; Collier DA; Elkin A; Williamson R; Young AH; Ferrier IN; Stefansson K; Stefansson H; Porgeirsson P; Steinberg S; Gustafsson O; Bergen SE; Nimgaonkar V; Hultman C; Landen M; Lichtenstein P; Sullivan P; Schalling M; Osby U; Backlund L; Frisen L; Langstrom N; Jamain S; Leboyer M; Etain B; Bellivier F; Petursson H; Sigurgosson E; Muller-Mysok B; Lucae S; Schwarz M; Schofield PR; Martin N; Montgomery GW; Lathrop M; Oskarsson H; Bauer M; Wright A; Mitchell PB; Hautzinger M; Reif A; Kelsoe JR; Purcell SM, 2011, 'Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4', Nature Genetics, 43, pp. 977 - 985, http://dx.doi.org/10.1038/ng.943

Lee P; Kengne A; Greenfield JR; Day RO; Chalmers J; Ho KK, 2011, 'Metabolic sequelae of beta-blocker theraphy: weighing in on the obesity epidemic?', International journal of obesity, 35, pp. 1395 - 1403, http://dx.doi.org/10.1038/ijo.2010.284

Brett J; Beresford R; Sevastos J; Day RO, 2011, 'Neem Extract Poisoning as a Cause of Renal Tubular Acidosis', Journal of Clinical Toxicology, 1, pp. 112, http://dx.doi.org/10.4172/2161-0495.1000112

Stocker SL; Graham GG; McLachlan AJ; Williams K; Day RO, 2011, 'Pharmacokinetic and Pharmacodynamic interaction between allopurinol and probenecid in patients with gout', Journal of Rheumatology, 38, pp. 904 - 910, http://dx.doi.org/10.3899/jrheum.101160

Bell AJ; Mcd taylor D; Holdgate A; MacBean C; Huynh T; Thom O; Augello M; Millar R; Day RE; Williams AG; Ritchie P; Pasco J, 2011, 'Procedural sedation practices in Australian Emergency Departments', Emergency Medicine Australasia, 23, pp. 458 - 465, http://dx.doi.org/10.1111/j.1742-6723.2011.01418.x

Inam S; Lipworth WL; Kerridge IH; Day RO, 2011, 'Rethinking the discordance between guidelines and practice in the treatment of rheumatoid arthritis: a failure of practice or failure of evidence?', Medical Journal of Australia, 195, pp. 446 - 447

Mcd taylor D; Bell AJ; Holdgate A; MacBean C; Huynh T; Thom O; Augello M; Millar R; Day RE; Williams AG; Ritchie P; Pasco J, 2011, 'Risk factors for sedation-related events during procedural sedation in the emergency departmentemm_1419 466..473', Emergency Medicine Australasia, 23, pp. 466 - 473, http://dx.doi.org/10.1111/j.1742-6723.2011.01419.x

Bombardier C; Laine L; Day RO; Hawkey CJ; Hochberg MC; Schnitzer TJ, 2011, 'Rofecoxib and clinically significant gastrointestinal events', American Journal of the Medical Sciences, 342, pp. 438 - 439, http://dx.doi.org/10.1097/MAJ.0b013e31822f3ff4

Harvey K; Day RO; Campbell W; Lipworth WL, 2011, 'Saving money on the PBS: Ranibizumab or Bevacizumab for Neovascular Macular Degeneration?', Medical Journal of Australia, 194, pp. 567 - 568

Baysari MT; Westbrook J; Richardson K; Day RO, 2011, 'The influence of computerized decision support on prescribing during ward rounds: are the decision-makers targeted?', Journal of the American Medical Informatics Association, 18, pp. 754 - 759, http://dx.doi.org/10.1136/amiajnl-2011-000135

Baysari MT; Westbrook J; Braithwaite J; Day R, 2011, 'The Role of Computerized Decision Support in Reducing Errors in Selecting Medicines for Prescription: Narrative Review', Drug Safety, 34, pp. 289 - 298, http://dx.doi.org/10.2165/11588200-000000000-00000

Greenfield JR; Graham GG; Day RO, 2011, 'The Use of Metformin in Diabetic Patients with Renal Impairment', Geriatric Medicine in General Practice, 8, pp. 26 - 29, http://search.informit.com.au/documentSummary;dn=109054076198131;res=IELHEA

Milder T; Williams K; Ritchie JE; Lipworth WL; Day RO, 2011, 'Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: Engagement with information and perceptions of risk', Age and Ageing, 40, pp. 254 - 259, http://dx.doi.org/10.1093/ageing/afq160

Carney SL; Gazarian M; Denholm JT; Reith DM; Penhall RK; Jenkins CR; Wilhelm KA; Komesaroff P; Osborn MM; Day RO, 2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651

Lipworth WL; Wodak A; Haber P; Day RO, 2011, 'Why is Disulfiram not on the PBS?', Medical Journal of Australia, 195, pp. 371 - 372

Roberts D; Chau A; Nair P, 2010, 'ENHANCED ELIMINATION OF PHENOBARBITAL USING CHARCOAL HAEMOPERFUSION IN A PATIENT WITH SEVERE POISONING', NEPHROLOGY, 15, pp. 87 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lu CY; Lu VH; Goldberg I; Day RO, 2010, 'Towards integrated care: Australia's new model of care for patients with glaucoma', Medical Journal of Australia, 193, pp. 200 - 201, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03867.x

Standfield L; Norris S; Harvey C; Elliot L; Riordan J; Hall S; Day R; Nash P; Thirunavukkarasu K; Robertson J; Palmer T, 2010, 'Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in australian patients: A cross-sectional, multicenter study', Clinical Therapeutics, 32, pp. 1329 - 1342, http://dx.doi.org/10.1016/j.clinthera.2010.07.006

Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'Erratum: FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable? (Inflammopharmacol DOI: 10.1007/s10787-010-0036-6)', Inflammopharmacology, 18, pp. 57, http://dx.doi.org/10.1007/s10787-010-0039-3

Carter SM; Samuel GN; Kerridge I; Day R; Ankeny RA; Jordens CFC; Komesaroff P, 2010, 'Beyond rhetoric in debates about the Ethics of marketing prescription medicines to consumers: The importance of Vulnerability in people, situations, and relationships', AJOB Primary Research, 1, pp. 11 - 21, http://dx.doi.org/10.1080/21507716.2010.482871

Day RO; Liauw WS; Tozer L; McElduff P; Beckett RJ; Williams K, 2010, 'A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenpausal women', BMC Research Notes, 3, pp. 1 - 8

Indraratna P; Stocker SL; Williams KM; Graham GG; Jones G; Day RO, 2010, 'A proposal for identifying the low renal uric acid clearance phenotype', Arthritis Research and Therapy, 12, pp. 149 - 151

Wallace H; Graham GG; Williams K; Day RO, 2010, 'A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine', Pain Medicine, 11, pp. 951 - 965

Westbrook JI; Woods A; Rob MI; Dunsmuir WTM; Day RO, 2010, 'Association of interruptions with an increased risk and severity of medication administration errors', Archives of Internal Medicine, 170, pp. 683 - 690, http://dx.doi.org/10.1001/archinternmed.2010.65

Magrabi F; Li S; Day RO; Coiera E, 2010, 'Errors and electronic prescribing: A controlled laboratory study to examine task complexity and interruption effects', American Medical Informatics Association Annual Symposium Proceedings, 17, pp. 575 - 583

Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'FDA proposals to limit the hepatoxicity of paracetamol (acetaminophen). Are they resonable?', Inflammopharmacology, 18, pp. 47 - 55

Stocker S; Franklin M; Anderson JM; Pillans PI; Williams K; McLachlan AJ; Day RO; taylor P, 2010, 'Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry', Journal of Chromatography, 878, pp. 2363 - 2368

Williams CM; Latimer J; Maher C; McLachlan AJ; Cooper C; Hancock M; Day RO; McAuley J; Lin C, 2010, 'PACE-the first placebo controlled trail of paracetamol for acute low back pain:design of a randomised controlled trial', BMC Musculoskeletal Disorders, 11, pp. 1 - 11, http://www.biomedcentral.com/content/pdf/1471-2474-11-169.pdf

Abdul M; Jiang XM; Williams KM; Day RO; Roufogalis B; Liauw WS; Xu H; Matthias A; Lehmann RP; McLachlan AJ, 2010, 'Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects', British Journal of Clinical Pharmacology, 69, pp. 508 - 515

Standfield L; Norris S; Elliott L; Riordan J; Hall S; Day RO; Nash P; Thirunavukkarasu K; Robertson J; Palmer T, 2010, 'Relationship between rheumatoid arthritis disease severity, health related utility and resource use in Australian rheumatoid arthritis patients', Clinical Therapeutics, 32, pp. 1329 - 1342

Day RO, 2009, 'Adherence to urate-lowering therapy', Southern Medical Journal, 102, pp. 114 - 115

Osborn M; Day RO; Westbrook JI, 2009, 'Are specialist physicians missing out on the e-Health boat?', Internal Medicine Journal, 39, pp. 655 - 661

Hancock M; Maher C; Latimer J; Mclachlan AJ; Day RO; Davies R, 2009, 'Can predictors of response to NSAIDs Be identified in patients with acute low back pain?', Clinical Journal of Pain, 25, pp. 659 - 665

Osborn M; Day RO; Komesaroff P; Mant A, 2009, 'Do ethical guidelines make a difference to decision-making?', Internal Medicine Journal, 39, pp. 800 - 805

Reckmann M; Westbrook JI; Koh Y; Lo CM; Day RO, 2009, 'Does Computerized Provider Order Entry Reduce Prescribing Errors for Hospital Inpatients? A Systematic Review', American Medical Informatics Association Annual Symposium Proceedings, 16, pp. 613 - 623

Indraratna P; Williams KM; Graham GG; Day RO, 2009, 'Hyperuricemia, Cardiovascular Disease and the Metabolic Syndrome', The Journal of Rheumatology, 36, pp. 2842 - 2843

Day RO, 2009, 'India: Emerging centre of drug develpment', Journal of Pharmacy Practice and Research, 39, pp. 262 - 263

Lee P; Greenfield JR; Day RO; Ho K, 2009, 'Weight maintenance in hospitalized geriatric patients treated with beta-blockers', Journal of the American Geriatrics Society, 57, pp. 1125 - 1126

Day RO; Fransen M; Zochling J; March L, 2008, 'Osteoarthritis: NSAIDs, paracetamol or other treatment approaches?', Medicine Today, 9, pp. 71 - 74

Lu CY; Macneill P; Williams K; Day R, 2008, 'Access to high cost medicines in Australia: Ethical perspectives', Australia and New Zealand Health Policy, 5, http://dx.doi.org/10.1186/1743-8462-5-4

Lee M; Graham GG; Williams KM; Day RO, 2008, 'A benefit-risk assessment of benzbromarone in the treatment of gout - was its withdrawal from the market in the best interest of patients?', Drug Safety, 31, pp. 643 - 665

Lu CY; Williams KM; Day RO, 2008, 'Access to biologic medicines for the treatment of rheumatic diseases: lessons from Australia', International Journal of Rheumatology, 11, pp. 11 - 14

Xu H; Liauw WS; Murray M; Day RO; Mclachlan AJ, 2008, 'Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide', British Journal of Pharmacology, 153, pp. 1579 - 1586, http://dx.doi.org/10.1038/sj.bjp.0707685

Magrabi F; Westbrook JI; Kidd MR; Day RO; Coiera E, 2008, 'Long-term patterns of online evidence retrieval use in general practice: A 12-month study', Journal of Medical Internet Research, 10

McLachlan AJ; Day RO; Williams KM; Graham GG, 2008, 'Maximising gout therapy', Australian Journal of Pharmacy, 89, pp. 86 - 88

Chung Y; Stocker S; Graham GG; Day RO, 2008, 'Optimizing therapy with allopurinol: Factors limiting hypouricemic efficacy', American Journal of the Medical Sciences, 335, pp. 219 - 226

Abdul M; Jiang XM; Day RO; Roufogalis B; Liauw WS; Xu H; Mclachlan AJ, 2008, 'Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects', British Journal of Pharmacology, 154, pp. 1691 - 1700

Stocker S; Williams KM; Mclachlan AJ; Graham GG; Day RO, 2008, 'Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects', Clinical Pharmacokinetics, 47, pp. 111 - 118

Chung YW; Lu CY; Graham GG; Mant A; Day RO, 2008, 'Utilization of allopurinol in the Australian community', Internal Medicine Journal, 38, pp. 388 - 395

Back to profile page